SOCS-1, -2, -3: Selective targets and functions downstream of the prolactin receptor

Molecular and Cellular Endocrinology

Volumn 158, Issue 1-2, 1999, Pages 45-54

  Tomic, S ^a   Chughtai, N ^a   Ali, S ^a  

^a Division of Hematology   (Canada)

Author keywords

Jak Stat; Prolactin Receptor; Signal transduction; SOCS

Indexed keywords

BETA CASEIN; PROLACTIN RECEPTOR; PROTEIN; PROTEIN TYROSINE PHOSPHATASE; STAT5 PROTEIN; SUPPRESSOR FACTOR;

ARTICLE; GENE ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; CARRIER PROTEINS; CELL LINE; DNA-BINDING PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JANUS KINASE 2; MILK PROTEINS; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; PROTO-ONCOGENE PROTEINS; RATS; RECEPTORS, PROLACTIN; REPRESSOR PROTEINS; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 0032721623     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00180-X     Document Type: Article

References (45)

1. Adams T.E., Hansen J.A., Starr R., Nicola N.A., Hilton D.J., Billestrup N. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling. J. Biol. Chem. 273:1998;1285-1287.
2. Ali S. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways. J. Biol. Chem. 273:1998;7709-7716.
3. Ali S., Pellegrini I., Kelly P.A. A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. J. Biol. Chem. 266:1991;20110-20117.
4. Ali S., Edery M., Pellegrini I., Lesueur L., Paly J., Djiane J., Kelly P.A. The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Mol. Endocrinol. 6:1992;1242-1248.
5. Ali S., Chen Z., Lebrun J.J., Vogel W., Kharitonenkov A., Kelly P.A., Ullrich A. PTP1D is a positive regulator of the prolactin signal leading to beta- casein promoter activation. EMBO J. 15:1996;135-142.
6. Auernhammer C.J., Chesnokova V., Bousquet C., Melmed S. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion. Mol. Endocrinol. 12:1998;954-961.
7. Ball R.K., Ziemiecki A., Schonenberger C.A., Reichmann E., Redmond S.M., Groner B. v-myc alters the response of a cloned mouse mammary epithelial cell line to lactogenic hormones. Mol. Endocrinol. 2:1988;133-142.
8. Bazan J.F. A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain. Biochem. Biophys. Res. Commun. 164:1989;788-795.
9. Berchtold S., Volarevic S., Moriggl R., Mercep M., Groner B. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Mol. Endocrinol. 12:1998;556-567.
10. Bjorbaek C., Elmquist J.K., Frantz J.D., Shoelson S.E., Flier J.S. Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell. 1:1998;619-625.
11. Boutin J.M., Jolicoeur C., Okamura H., Gagnon J., Edery M., Shirota M., Banville D., Dusanter-Fourt I., Djiane J., Kelly P.A. Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell. 53:1988;69-77.
12. Darnell J.E. Jr, Kerr I.M., Stark G.R. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1994;1415-1421.
13. DaSilva L., Rui H., Erwin R.A., Howard O.M., Kirken R.A., Malabarba M.G., Hackett R.H., Larner A.C., Farrar W.L. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580. Mol. Cell. Endocrinol. 117:1996;131-140.
14. Dey B.R., Spence S.L., Nissley P., Furlanetto R.W. Interaction of human suppressor of cytokine signaling (SOCS)-2 with the insulin-like growth factor-I receptor. J. Biol. Chem. 273:1998;24095-24101.
15. Endo T.A., Masuhara M., Yokouchi M., Suzuki R., Sakamoto H., Mitsui K., Matsumoto A., Tanimura S., Ohtsubo M., Misawa H., Miyazaki T., Leonor N., Taniguchi T., Fujita T., Kanakura Y., Komiya S., Yoshimura A. A new protein containing an SH2 domain that inhibits JAK kinases. Nature. 387:1997;921-924.
16. Fuhrer D.K., Feng G.S., Yang Y.C. Syp associates with gp130 and Janus kinase 2 in response to interleukin- 11 in 3T3-L1 mouse preadipocytes. J. Biol. Chem. 270:1995;24826-24830.
17. Gouilleux F., Wakao H., Mundt M., Groner B. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13:1994;4361-4369.
18. Helman D., Sandowski Y., Cohen Y., Matsumoto A., Yoshimura A., Merchav S., Gertler A. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling. FEBS Lett. 441:1998;287-291.
19. Hilton D.J., Richardson R.T., Alexander W.S., Viney E.M., Willson T.A., Sprigg N.S., Starr R., Nicholson S.E., Metcalf D., Nicola N.A. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc. Natl. Acad. Sci. USA. 95:1998;114-119.
20. Ihle J.N., Witthuhn B.A., Quelle F.W., Yamamoto K., Silvennoinen O. Signaling through the hematopoietic cytokine receptors. Annu. Rev. Immunol. 13:1995;369-398.
21. Ihle J.N. Cytokine receptor signalling. Nature. 377:1995;591-594.
22. Jiao H., Berrada K., Yang W., Tabrizi M., Platanias L.C., Yi T. Direct association with and dephosphorylation of Jak2 kinase by the SH2- domain-containing protein tyrosine phosphatase SHP-1. Mol. Cell. Biol. 16:1996;6985-6992.
23. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G. Jr, Conaway R.C., Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:1998;3872-3881.
24. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729-738.
25. Lebrun J.J., Ali S., Sofer L., Ullrich A., Kelly P.A. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J. Biol. Chem. 269:1994;14021-14026.
26. Lebrun J.J., Ali S., Ullrich A., Kelly P.A. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 270:1995;10664-10670.
27. Lebrun J.J., Ali S., Goffin V., Ullrich A., Kelly P.A. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. USA. 92:1995;4031-4035.
28. Liu X., Robinson G.W., Gouilleux F., Groner B., Hennighausen L. Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc. Natl. Acad. Sci. USA. 92:1995;8831-8835.
29. Liu X., Robinson G.W., Hennighausen L. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol. Endocrinol. 10:1996;1496-1506.
30. Losman J.A., Chen X.P., Hilton D., Rothman P. Cutting Edge: SOCS-1 Is a Potent Inhibitor of IL-4 Signal Transduction. J. Immunol. 162:1999;3770-3774.
31. Naka T., Narazaki M., Hirata M., Matsumoto T., Minamoto S., Aono A., Nishimoto N., Kajita T., Taga T., Yoshizaki K., Akira S., Kishimoto T. Structure and function of a new STAT-induced STAT inhibitor. Nature. 387:1997;924-929.
32. Nicholson S.E., Willson T.A., Farley A., Starr R., Zhang J.G., Baca M., Alexander W.S., Metcalf D., Hilton D.J., Nicola N.A. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction. EMBO J. 18:1999;375-385.
33. Ohya K., Kajigaya S., Yamashita Y., Miyazato A., Hatake K., Miura Y., Ikeda U., Shimada K., Ozawa K., Mano H. SOCS-1/JAB/SSI-1 can bind to and suppress Tec protein-tyrosine kinase. J. Biol. Chem. 272:1997;27178-27182.
34. Rui H., Lebrun J.J., Kirken R.A., Kelly P.A., Farrar W.L. JAK2 activation and cell proliferation induced by antibody-mediated prolactin receptor dimerization [see comments]. Endocrinology. 135:1994;1299-1306.
35. Rui H., Kirken R.A., Farrar W.L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269:1994;5364-5368.
36. Shen S.H., Bastien L., Posner B.I., Chretien P. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases [published erratum appears in Nature 1991 Oct 31;353(6347):868]. Nature. 352:1991;736-739.
37. Shirota M., Banville D., Ali S., Jolicoeur C., Boutin J.M., Edery M., Djiane J., Kelly P.A. Expression of two forms of prolactin receptor in rat ovary and liver. Mol. Endocrinol. 4:1990;1136-1143.
38. Song M.M., Shuai K. The suppressor of cytokine signaling (SOCS) 1 and SOCS3 but not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273:1998;35056-35062.
39. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature. 387:1997;917-921.
40. Suzuki R., Sakamoto H., Yasukawa H., Masuhara M., Wakioka T., Sasaki A., Yuge K., Komiya S., Inoue A., Yoshimura A. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells. Oncogene. 17:1998;2271-2278.
41. Tauchi T., Feng G.S., Shen R., Hoatlin M., Bagby G.C. Jr, Kabat D., Lu L., Broxmeyer H.E. Involvement of SH2-containing phosphotyrosine phosphatase Syp in erythropoietin receptor signal transduction pathways. J. Biol. Chem. 270:1995;5631-5635.
42. Wakao H., Gouilleux F., Groner B. Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response [published erratum appears in EMBO J. 1995 Feb 15;14(4):854-5]. EMBO J. 13:1994;2182-2191.
43. Welham M.J., Dechert U., Leslie K.B., Jirik F., Schrader J.W. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase. J. Biol. Chem. 269:1994;23764-23768.
44. Yoshimura A., Ohkubo T., Kiguchi T., Jenkins N.A., Gilbert D.J., Copeland N.G., Hara T., Miyajima A. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors. EMBO J. 14:1995;2816-2826.
45. Zhang J.G., Farley A., Nicholson S.E., Willson T.A., Zugaro L.M., Simpson R.J., Moritz R.L., Cary D., Richardson R., Hausmann G., Kile B.J., Kent S.B., Alexander W.S., Metcalf D., Hilton D.J., Nicola N.A., Baca M. The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation [In Process Citation]. Proc. Natl. Acad. Sci. USA. 96:1999;2071-2076.